172 related articles for article (PubMed ID: 8247177)
1. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis.
Esnault VL; Testa A; Jayne DR; Soulillou JP; Guenel J
Nephron; 1993; 65(2):180-4. PubMed ID: 8247177
[TBL] [Abstract][Full Text] [Related]
2. Immunoadsorption in Autoimmune Diseases Affecting the Kidney.
Stummvoll G; Aringer M; Handisurya A; Derfler K
Semin Nephrol; 2017 Sep; 37(5):478-487. PubMed ID: 28863794
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S
Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
[No Abstract] [Full Text] [Related]
4. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
5. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide.
Palmer A; Cairns T; Dische F; Gluck G; Gjorstrup P; Parsons V; Welsh K; Taube D
Nephrol Dial Transplant; 1991; 6(8):536-42. PubMed ID: 1956551
[TBL] [Abstract][Full Text] [Related]
6. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption in Anti-GBM Glomerulonephritis: Case Report in a Child and Literature Review.
Dorval G; Lion M; Guérin S; Krid S; Galmiche-Rolland L; Salomon R; Boyer O
Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29054981
[TBL] [Abstract][Full Text] [Related]
8. New strategies for plasma exchange in systemic vasculitis.
Jayne DR
Transfus Sci; 1990; 11(3-4):263-9. PubMed ID: 10149528
[TBL] [Abstract][Full Text] [Related]
9. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic therapy for glomerulonephritis with combined immunoadsorption and IVIG therapy].
Welcker M; Helmke K
Immun Infekt; 1995 Aug; 23(4):140-1. PubMed ID: 7558119
[TBL] [Abstract][Full Text] [Related]
11. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
[TBL] [Abstract][Full Text] [Related]
12. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
[TBL] [Abstract][Full Text] [Related]
13. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
Szpirt W; Somnier F; Nielsen FC; Rødgaard A
Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
[No Abstract] [Full Text] [Related]
14. Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane.
Pusey CD; Lockwood CM; Peters DK
Int J Artif Organs; 1983 Jul; 6 Suppl 1():15-8. PubMed ID: 6642729
[TBL] [Abstract][Full Text] [Related]
15. [Renal vasculitis and glomerulonephritis with anti-neutrophil cytoplasmic antibody positivity].
Tesar V; Rychlík I; Bartůnková J; Stejsakalová A; Zabka J; Janatková I; Fucíková T; Becvár R
Cas Lek Cesk; 1996 Jan; 135(3):79-83. PubMed ID: 8625374
[TBL] [Abstract][Full Text] [Related]
16. 'Pauci-immune' rapidly progressive glomerulonephritis associated with systemic vasculitis.
Han JY; Yoon SA; Woo JY; Park IS; Kim SY; Chang YS; Bang BK
J Korean Med Sci; 1992 Sep; 7(3):264-70. PubMed ID: 1285926
[TBL] [Abstract][Full Text] [Related]
17. Antiglomerular basement membrane antibody-crescentic glomerulonephritis complicating chronic bronchiectasis.
Enríquez R; Cabezuelo JB; Sirvent AE; Andrada E; Amorós F; Orti C
Scand J Urol Nephrol; 2001 Apr; 35(2):156-7. PubMed ID: 11411662
[TBL] [Abstract][Full Text] [Related]
18. [Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].
Haris A; Arányi J; Braunitzer H; Kálmán E; Merán Z; Soltész M; Polner K
Orv Hetil; 2011 Jul; 152(28):1110-9. PubMed ID: 21712172
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.
Kronbichler A; Brezina B; Quintana LF; Jayne DR
Autoimmun Rev; 2016 Jan; 15(1):38-49. PubMed ID: 26318215
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
